Literature DB >> 15280854

Progressive epidermotropic CD8+/CD4- primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis.

Joel M Gelfand1, Mariusz A Wasik, Carmela Vittorio, Alain Rook, Jacqueline M Junkins-Hopkins.   

Abstract

We describe a patient with a CD8+/CD4- primary cutaneous CD30(+) lymphoproliferative disorder with striking epidermotropic histology and coincident cutaneous and systemic sarcoidosis. This patient illustrates the spectrum of clinical and histologic features of CD30+ lymphoproliferative disorders and the need for adequate staging in such cases. This patient's CD30/CD8 coexpression is rare and has clinical and prognostic implications, including mucosally and acrally accentuated lesions and a potentially more aggressive course. Primary cutaneous CD30+ lymphoproliferative disorders have an excellent prognosis; therefore multiagent chemotherapy modalities are generally not indicated. The combination of T-cell lymphoma and sarcoidosis is also rare and may limit treatment options.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280854     DOI: 10.1016/s0190-9622(03)00065-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Sarcoidosis and cutaneous lymphoma: What is the relationship?

Authors:  Vanessa Gargallo; Jéssica González Ramos; José Luis Rodríguez-Peralto; Concepción Postigo
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

2.  Primary Cutaneous CD8(+) CD30(+) Anaplastic Large Cell Lymphoma: An Unusual Case with a High Ki-67 index-A Short Review.

Authors:  Jitendra G Nasit; Smita C Patel
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.